The new cleanroom at our global headquarters in Salt Lake City, Utah, was designed for today's rigorous contamination control expectations, driven by EU GMP Annex 1. Learn More
Blog Post 12 – Bridging Analytical Gaps: Identification of GC/MS Impurities from External Labs 3 min reading time At Nelson Labs, we regularly assist customers with impurity investigations performed either by the drug product manufacturer or another CRO. These cases...
Blog Post 9 – Through the Lens of GC/QTOF: Tracking Down Impurities in Ophthalmics 3 min reading time In the development of ophthalmic drug products, impurity profiling is essential to ensure long-term safety and regulatory compliance. While many impurities are...
Learn from the industry-leading experts at Nelson Laboratories in the three-day webinar series Medical Device and Pharmaceutical Testing Regulatory Updates, Trends, and Anticipated Changes including FDA, ISO, USP, and MDRs. The experts at Nelson Labs are teaming with MD+DI to...
Over the past few years, as medical device manufacturers look for new and innovative ways to package, sterilize, and market their products, the use of non-porous materials in packaging has become more and more popular. Similar to porous packaging, non-porous...
With DuPont’s Tyvek transition looming, manufacturers should consider performing a packaging validation as part of their implementation strategy. Nelson Laboratories has been working with the new Tyvek material, testing it according to the ASTM F2638 method, for several years. DuPont...
